• Kyodo

  • SHARE

The world’s first clinical research using induced pluripotent stem cells, known as iPS cells, for the regeneration of retina begins Thursday, according to a Japanese team of researchers.

The state-backed scientific research institute Riken, based in Wako, Saitama Prefecture, and the Foundation for Biomedical Research and Innovation based in Kobe applied in February for government permission to conduct clinical research.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW